This one-and-a-half-day event will provide attendees with information about pharmaceutical and device innovations, advancements, and regulatory issues related to sleep, circadian rhythms, and disorders associated with daytime sleepiness and disturbed sleep.

The event faculty is comprised of world-renowned investigators, key opinion leaders from industry, and regulatory representatives from the Food and Drug Administration. The event will include both didactic lectures and panel discussions to foster an engaging environment. Numerous collaboration and networking opportunities for all attendees have been built into the event’s agenda. All registration and ticket proceeds for the event will be awarded to the Sleep Research Society Foundation to enhance their early-career investigator program, ensuring the best and brightest minds have available funding to launch their careers in the field of sleep and circadian research.